These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 18635789

  • 1. Collateral damage. The rise of resistant C. difficile.
    Taubes G.
    Science; 2008 Jul 18; 321(5887):360. PubMed ID: 18635789
    [No Abstract] [Full Text] [Related]

  • 2. Clostridium difficile and fluoroquinolones: is there a link?
    Weiss K.
    Int J Antimicrob Agents; 2009 Mar 18; 33 Suppl 1():S29-32. PubMed ID: 19303566
    [Abstract] [Full Text] [Related]

  • 3. Epidemic Clostridium difficile.
    Wilcox MH, Freeman J.
    N Engl J Med; 2006 Mar 16; 354(11):1199-203; author reply 1199-203. PubMed ID: 16544390
    [No Abstract] [Full Text] [Related]

  • 4. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.
    Khanna S, Pardi DS.
    Expert Rev Gastroenterol Hepatol; 2010 Aug 16; 4(4):409-16. PubMed ID: 20678014
    [Abstract] [Full Text] [Related]

  • 5. Clostridium difficile--more difficult than ever.
    Kelly CP, LaMont JT.
    N Engl J Med; 2008 Oct 30; 359(18):1932-40. PubMed ID: 18971494
    [No Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.
    Bourgault AM, Lamothe F, Loo VG, Poirier L, CDAD-CSI Study Group.
    Antimicrob Agents Chemother; 2006 Oct 30; 50(10):3473-5. PubMed ID: 17005836
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clostridium difficile infections: an unexpected re-emergence].
    Barbut F.
    Pathol Biol (Paris); 2008 Feb 30; 56(1):6-9. PubMed ID: 18178330
    [No Abstract] [Full Text] [Related]

  • 14. Clostridium difficile-associated diarrhoea.
    Elliott B, Chang BJ, Golledge CL, Riley TV.
    Intern Med J; 2007 Aug 30; 37(8):561-8. PubMed ID: 17640189
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Implications of the changing face of Clostridium difficile disease for health care practitioners.
    McFarland LV, Beneda HW, Clarridge JE, Raugi GJ.
    Am J Infect Control; 2007 May 30; 35(4):237-53. PubMed ID: 17482995
    [Abstract] [Full Text] [Related]

  • 17. [Clostridium difficile ribotype 027, toxinotype III in The Netherlands].
    Kuijper EJ, Debast SB, Van Kregten E, Vaessen N, Notermans DW, van den Broek PJ.
    Ned Tijdschr Geneeskd; 2005 Sep 17; 149(38):2087-9. PubMed ID: 16201596
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.